triiodothyronine has been researched along with triazolam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Doyle, D; Kragie, L | 1 |
1 review(s) available for triiodothyronine and triazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for triiodothyronine and triazolam
| Article | Year |
|---|---|
Benzodiazepines inhibit temperature-dependent L-[125I]triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines.
Topics: Adenoma; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Cell Line; Convulsants; Diazepam; Dose-Response Relationship, Drug; Humans; Iodine Radioisotopes; Liver; Lorazepam; Neuroblastoma; Pituitary Neoplasms; Rats; Receptors, Thyroid Hormone; Temperature; Triazolam; Triiodothyronine; Tritium; Tumor Cells, Cultured | 1992 |